Cimetidine suspension in patients with Stage 0 gastro‐oesophageal reflux disease
- 1 April 1991
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 5 (2) , 191-197
- https://doi.org/10.1111/j.1365-2036.1991.tb00020.x
Abstract
One hundred and twenty-five patients with symptoms of heartburn and acid regurgitation but without endoscopic abnormalities were randomized to receive 200 mg cimetidine suspension four times daily or placebo for two weeks. Daily dairy cards were kept to evaluate the frequency and degree of symptoms. At two weeks cimetidine was significantly more effective than placebo. It is concluded that placebo suspension has a considerable effect on gastro-oesophageal reflux disease symptoms, but cimetidine suspension provides significantly better relief.Keywords
This publication has 7 references indexed in Scilit:
- Sensitivity of the Esophageal Mucosa to pH in Gastroesophageal Reflux DiseaseGastroenterology, 1989
- Medical Therapy of Reflux EsophagitisPublished by Springer Nature ,1988
- Conservative Therapy of Gastroesophageal RefluxPublished by Springer Nature ,1988
- Gastroesophageal refluxPostgraduate Medicine, 1987
- Symptoms and Endoscopic Findings in the Diagnosis of Gastroesophageal Reflux DiseaseScandinavian Journal of Gastroenterology, 1987
- Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitisDigestive Diseases and Sciences, 1983